Milestone Scientific, Inc. Common Stock (MLSS) Stock Price

MLSSStock

$0.33−26.66%52W

Market Cap$29.58M

P/E—

PEG Ratio—

Div yield—

Beta1.20

MLSS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)1.91%

Price vs S&P 500 (4W)-15.13%

VGM Score41.93

Book Value / Share (Quarterly)$0.04

P/TBV (Annual)7.85x

Revenue Growth (3Y)0.62%

Cash Flow / Share (Quarterly)$-0.01

Price vs S&P 500 (YTD)7.67%

Gross Margin (TTM)70.23%

Net Profit Margin (TTM)-43.98%

EPS (TTM)$-0.05

10-Day Avg Trading Volume0.09M

EPS Excl Extra (TTM)$-0.05

Revenue Growth (5Y)10.53%

EPS (Annual)$-0.07

ROI (Annual)-156.03%

Gross Margin (Annual)71.40%

Net Profit Margin (5Y Avg)-70.79%

Cash / Share (Quarterly)$0.02

Revenue Growth QoQ (YoY)22.28%

ROA (Last FY)-73.30%

Revenue Growth TTM (YoY)3.72%

EBITD / Share (TTM)$-0.05

ROE (5Y Avg)-99.51%

Operating Margin (TTM)-43.56%

Cash Flow / Share (Annual)$-0.04

P/B Ratio8.53x

P/B Ratio (Quarterly)8.18x

Net Income / Employee (Annual)$-381,500

EV / Revenue (TTM)2.98x

Net Interest Coverage (TTM)-222.52x

ROA (TTM)-50.84%

EV / EBITDA (TTM)49.20x

EPS Incl Extra (Annual)$-0.07

Current Ratio (Annual)1.81x

Quick Ratio (Quarterly)0.71x

3-Month Avg Trading Volume0.14M

52-Week Price Return-26.66%

Revenue / Employee (TTM)$628,100

Tangible BV / Share (Quarterly)$0.04

P/S Ratio (Annual)3.30x

Asset Turnover (Annual)1.15x

52-Week High$0.58

Operating Margin (5Y Avg)-72.05%

EPS Excl Extra (Annual)$-0.07

CapEx CAGR (5Y)-5.44%

Tangible BV CAGR (5Y)-29.66%

26-Week Price Return11.82%

Quick Ratio (Annual)0.44x

13-Week Price Return-25.29%

Total Debt / Equity (Annual)0.30x

Current Ratio (Quarterly)1.85x

Enterprise Value$28.04M

Revenue / Share Growth (5Y)4.86%

Asset Turnover (TTM)1.16x

Book Value / Share Growth (5Y)-32.65%

Revenue / Employee (Annual)$598,300

Inventory Turnover (Annual)0.50x

Pretax Margin (Annual)-63.76%

Cash / Share (Annual)$0.01

3-Month Return Std Dev70.40%

Gross Margin (5Y Avg)66.39%

Net Income / Employee (TTM)$-276,200

ROE (Last FY)-203.45%

Net Interest Coverage (Annual)-72.16x

EPS Basic Excl Extra (Annual)$-0.07

P/FCF (TTM)184.11x

Receivables Turnover (TTM)11.06x

Total Debt / Equity (Quarterly)0.15x

EPS Incl Extra (TTM)$-0.05

Receivables Turnover (Annual)15.19x

ROI (TTM)-116.76%

P/S Ratio (TTM)3.14x

Pretax Margin (5Y Avg)-71.62%

Revenue / Share (Annual)$0.11

Tangible BV / Share (Annual)$0.03

Price vs S&P 500 (52W)-42.19%

Year-to-Date Return19.60%

5-Day Price Return-6.18%

EPS Normalized (Annual)$-0.07

ROA (5Y Avg)-56.07%

Net Profit Margin (Annual)-63.76%

Month-to-Date Return-18.60%

Cash Flow / Share (TTM)$-0.10

EBITD / Share (Annual)$-0.07

Operating Margin (Annual)-63.48%

LT Debt / Equity (Annual)0.28x

ROI (5Y Avg)-89.77%

LT Debt / Equity (Quarterly)0.13x

EPS Basic Excl Extra (TTM)$-0.05

P/TBV (Quarterly)8.29x

P/B Ratio (Annual)7.63x

Inventory Turnover (TTM)0.60x

Pretax Margin (TTM)-43.98%

Book Value / Share (Annual)$0.04

Price vs S&P 500 (13W)-27.97%

Beta1.20x

P/FCF (Annual)105.70x

Revenue / Share (TTM)$0.10

ROE (TTM)-149.08%

52-Week Low$0.22

vGradeD

gGradeC

mGradeC

vgmGradeC

MLSS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$0.01	-$0.01	+0.00%(+$0.00)
Q1 2026	May 13, 2026	-$0.01	-$0.01	+33.33%(+$0.01)
Q4 2025	Mar 31, 2026	-$0.01	-$0.01	+33.33%(+$0.01)
Q3 2025	Nov 13, 2025	-$0.01	-$0.01	+0.00%(+$0.00)
Q2 2025	Aug 14, 2025	-$0.01	-$0.02	-100.00%(-$0.01)

MLSS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.13

Industry Peers — Orthopedic & Prosthetic Devices(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
MLSSMilestone Scientific, Inc. Common Stock	D	C	C	3.1x	10.5%	70.2%	-43.6%	$0.33
ISRGIntuitive Surgical Inc.	D	B	B	13.7x	18.2%	66.7%	31.3%	$426.70
EWEdwards Lifesciences Corp	D	C	B	7.7x	6.7%	77.8%	18.2%	$86.60
STESTERIS plc	C	C	B	3.6x	13.8%	44.4%	18.9%	$222.66
ZBHZimmer Biomet Holdings, Inc.	B	C	B	2.1x	3.2%	69.9%	14.2%	$94.98
SNNSmith & Nephew plc	B	C	C	1.9x	6.2%	68.2%	12.9%	$29.06
ALGNAlign Technology Inc	B	D	C	2.5x	10.3%	69.0%	13.2%	$147.31
MSAMine Safety Incorporated	C	C	B	3.5x	6.8%	47.6%	21.2%	$179.05
ESTAEstablishment Labs Holdings Inc.	F	A	C	7.2x	20.0%	70.5%	-7.6%	$59.18
ENOVEnovis Corporation	B	D	C	0.5x	-6.0%	61.4%	-45.1%	$19.59
CDRECadre Holdings, Inc.	B	C	C	1.6x	8.6%	41.8%	10.1%	$26.38
AVRAnteris Technologies Global Corp. Common Stock	D	C	C	263.0x	—	75.0%	-4738.4%	$6.05
SMTISanara MedTech Inc. Common Stock	D	C	B	2.8x	45.9%	93.0%	7.7%	$33.16
INGNInogen Inc	B	D	C	0.5x	2.5%	44.5%	-8.7%	$6.25
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	F	D	C	6.3x	5.0%	29.2%	2.9%	$2.08
LAKELakeland Industries Inc	B	D	D	0.5x	3.9%	32.6%	-4.1%	$9.09
CNXUConexeu Sciences Inc. Common Stock	—	—	F	—	—	—	—	$3.06
NTRBNutriband Inc. Common Stock	F	D	B	46.7x	16.6%	33.1%	-435.6%	$6.22
SPAISafe Pro Group Inc. Common Stock	F	A	D	23.3x	—	62.2%	-513.8%	$3.30
APTAlpha Pro Tech, Ltd.	A	D	B	0.9x	-10.4%	37.5%	7.5%	$5.55
COCHEnvoy Medical, Inc. Class A Common Stock	F	F	C	249.8x	—	-385.5%	-11411.1%	$0.67
MYOMyomo Inc.	B	B	B	1.1x	40.1%	68.3%	-27.1%	$1.20
LFWDLifeward Ltd. Ordinary Shares	A	C	C	1.1x	38.1%	32.9%	-125.5%	$6.00
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	F	196.5x	—	-0.4%	-9352.8%	$1.90
RGNTRegentis Biomaterials Ltd.	—	—	D	—	—	—	—	$1.49
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	D	F	C	17.6x	-17.3%	-147.6%	-3329.1%	$3.63
BBLGBone Biologics Corp Common Stock	—	—	F	—	—	—	—	$0.40
FEEDENvue Medical, Inc. Common Stock	—	F	F	0.2x	—	-26.1%	-1362.7%	$0.37
AVNSAvanos Medical, Inc.	B	D	B	1.6x	-0.4%	50.0%	-8.8%	$0.00
BBLGWBone Biologics Corp Warrants	—	—	D	—	—	—	—	$7.70
COCHWEnvoy Medical, Inc Warrant	—	—	D	—	—	—	—	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	—	—	—	—	$0.55

About Milestone Scientific, Inc. Common Stock

Milestone Scientific Inc. manufactures proprietary, computer-controlled systems for delivering local anesthetics with improved comfort and reduced pain. The company serves the dental market through its CompuDent system and the medical market through its CompuMed system.

MLSS Next Earnings Report

Report dateNov 12, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.01

Revenue estimate$2.41M

Also reporting on Nov 12, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

QTIQT Imaging Holdings, Inc. Common StockElectromedical Equipment
CVRXCVRx, Inc. Common StockSurgical & Medical Instruments
BCHTBirchtech Corp.Measuring & Controlling Devices
PMIPicard Medical, Inc.Surgical & Medical Instruments
ITOCiTonic Holdings Ltd Class A Ordinary SharesElectromedical Equipment
DAIOData I/O CorpInstruments for Measuring
BEATHeartbeam, Inc. Common StockSurgical & Medical Instruments
PLRZPolyrizon Ltd. Ordinary SharesSurgical & Medical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$0.22

High$0.58